Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
AMES Carrascoso, CR Bertozzi, CB Lebrilla… - US Patent …, 2020 - Google Patents
Provided herein are methods for identifying new biomarkers for various diseases using
proteomics, peptidomics, metabolics, proteoglycomics, glvcomics, mass spectrometry and …
proteomics, peptidomics, metabolics, proteoglycomics, glvcomics, mass spectrometry and …
Predictive biomarkers for ovarian cancer
BC Mansfield, PF Yip, S Amonkar… - US Patent …, 2017 - Google Patents
Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as
well as for assessing the therapeutic efficacy of a cancer treatment and determining whether …
well as for assessing the therapeutic efficacy of a cancer treatment and determining whether …
Predictive biomarkers for ovarian cancer
BC Mansfield, PF Yip, S Amonkar… - US Patent …, 2020 - Google Patents
US10605811B2 - Predictive biomarkers for ovarian cancer - Google Patents
US10605811B2 - Predictive biomarkers for ovarian cancer - Google Patents Predictive …
US10605811B2 - Predictive biomarkers for ovarian cancer - Google Patents Predictive …
Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
AMES Carrascoso, CR Bertozzi, CB Lebrilla… - US Patent …, 2023 - Google Patents
2021-06-04 Assigned to VENN BIOSCIENCES CORPORATION reassignment VENN
BIOSCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
BIOSCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
[引用][C] The effect of silent signal transduction and transcriptional activation factor 3 on the expression of tenascin-C in ovarian cancer cell line SKOV-3
J Yan, J Rongying, L Jiebing